Clinical Trial Update: An Efficacy, Safety, and Tolerability Study for TA-7284 in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

This document reports Phase 2 results for TA-7284 in patients with Type 2 Diabetes Mellitus, including efficacy, safety, and tolerability assessments, with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• TA-7284

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2014-06-05